Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Antonio García-Merino. (2013) Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. Expert Review of Neurotherapeutics 13:sup1, pages 9-13.
Read now
Read now
Articles from other publishers (24)
Aruna Raja, Soha Ahmadi, Fernanda de Costa, Nan Li & Kagan Kerman. (2020) Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells. Pharmaceuticals 13:11, pages 328.
Crossref
Crossref
Letizia Leocani, Arturo Nuara, Elise Houdayer, Irene Schiavetti, Ubaldo Del Carro, Stefano Amadio, Laura Straffi, Paolo Rossi, Vittorio Martinelli, Carlos Vila, Maria Pia Sormani & Giancarlo Comi. (2015) Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis. Journal of Neurology 262:11, pages 2520-2527.
Crossref
Crossref
Javier Fernández-Ruiz, Mariluz Hernández & Yolanda García-Movellán. 2014. Cannabinoids. Cannabinoids
175
218
.
Mattias Svensson, Puran Chen & Oscar Hammarfjord. (2010) Dendritic Cell Regulation by Cannabinoid-Based Drugs. Pharmaceuticals 3:8, pages 2733-2750.
Crossref
Crossref
Muthu D. Bhaskaran & Bret N. Smith. (2010) Cannabinoid-Mediated Inhibition of Recurrent Excitatory Circuitry in the Dentate Gyrus in a Mouse Model of Temporal Lobe Epilepsy. PLoS ONE 5:5, pages e10683.
Crossref
Crossref
Sonja A. Grundmann & Sonja Ständer. 2009. Skin Moisturization. Skin Moisturization
377
390
.
M Gironi, F Martinelli-Boneschi, P Sacerdote, C Solaro, M Zaffaroni, R Cavarretta, L Moiola, S Bucello, M Radaelli, V Pilato, ME Rodegher, M Cursi, S Franchi, V Martinelli, R Nemni, G Comi & G Martino. (2008) A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Multiple Sclerosis Journal 14:8, pages 1076-1083.
Crossref
Crossref
Gregory L. Gerdeman & Javier Fernández-Ruiz. 2008. Cannabinoids and the Brain. Cannabinoids and the Brain
423
483
.
Carmen Espejo & Roland Martin. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
Pál Pacher, Sándor Bátkai & George Kunos. (2006) The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological Reviews 58:3, pages 389-462.
Crossref
Crossref
Allyn C. Howlett, Somnath Mukhopadhyay & Derek C. Norford. (2006) Endocannabinoids and Reactive Nitrogen and Oxygen Species in Neuropathologies. Journal of Neuroimmune Pharmacology 1:3, pages 305-316.
Crossref
Crossref
Ana Cabranes, Gareth Pryce, David Baker & Javier Fernández-Ruiz. (2006) Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice. Brain Research 1107:1, pages 199-205.
Crossref
Crossref
Eva de Lago, Javier Fernández-Ruiz, Silvia Ortega-Gutiérrez, Ana Cabranes, Gareth Pryce, David Baker, Mariluz López-Rodríguez & José Antonio Ramos. (2006) UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. European Neuropsychopharmacology 16:1, pages 7-18.
Crossref
Crossref
. 2006. McAlpine's Multiple Sclerosis. McAlpine's Multiple Sclerosis
811
946
.
Rosario de Miguel, José Ramos, Maribel Cebeira, Mariluz Hernández & Javier Fernández-Ruiz. 2005. Endocannabinoids. Endocannabinoids.
Ana Cabranes, Katerina Venderova, Eva de Lago, Filomena Fezza, Antonio Sánchez, Leyre Mestre, Marta Valenti, Antonio García-Merino, José Antonio Ramos, Vincenzo Di Marzo & Javier Fernández-Ruiz. (2005) Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiology of Disease 20:2, pages 207-217.
Crossref
Crossref
Sonja Ständer, Martin Schmelz, Dieter Metze, Thomas Luger & Roman Rukwied. (2005) Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. Journal of Dermatological Science 38:3, pages 177-188.
Crossref
Crossref
Thomas W. Klein. (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Reviews Immunology 5:5, pages 400-411.
Crossref
Crossref
Javier Fernández-Ruiz, Sara González, Julián Romero & José Antonio Ramos. 2005. Cannabinoids as Therapeutics. Cannabinoids as Therapeutics
79
109
.
J. Fernández-Ruiz & S. González. 2005. Cannabinoids. Cannabinoids
479
507
.
Beat Lutz. (2004) On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochemical Pharmacology 68:9, pages 1691-1698.
Crossref
Crossref
Murat Oz, Yulia Tchugunova & Meral Dinc. (2004) Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids. European Journal of Pharmacology 502:1-2, pages 47-58.
Crossref
Crossref
Pierre-Charles Boudrias. (2004) La question du cannabis thérapeutique . Drogues, santé et société 2:2.
Crossref
Crossref
Manuel Guzmán. (2003) Cannabinoids: potential anticancer agents. Nature Reviews Cancer 3:10, pages 745-755.
Crossref
Crossref